The gut-brain hormone glucagon-like peptide-1 (GLP-1) has received immense attention
over the last couple of decades for its widespread metabolic effects. Notably, intestinal GLP …

Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone released in response to meal
ingestion and enhances insulin secretion from pancreatic β cells. In several human studies …

Nowadays, high epidemic obesity-triggered hypertension and diabetes seriously damage
social public health. There is now a general consensus that the body's fat content exceeding …

The incretin hormone glucagon-like peptide-1 (GLP-1) is secreted by the intestinal L cell in
response to nutrient intake. However, GLP-1 secretion also follows a circadian rhythm which …

The significant growth in type 2 diabetes mellitus (T2DM) prevalence strikes a common
threat to the healthcare and economic systems globally. Despite the availability of several …

Glucagon-like peptide-1 (GLP-1) is a gastrointestinal hormone released from
enteroendocrine L cells in response to meal ingestion. GLP-1 receptor agonists and GLP-1 …

Obesity continues to be a global health issue. According to the World Health Organization
(WHO), its prevalence has increased almost 3-fold between 1975 and 2016; thirteen percent …

This study examined the effects of a combination of soybean fiber and α-glycosyl-
isoquercitrin (AGIQ) on improving quercetin bioavailability and glucose metabolism in rats …

Glucagon-like peptide-1 (GLP-1) is postprandially secreted from enteroendocrine L-cells
and enhances insulin secretion. Currently, it is still controversial whether postprandial GLP-1 …

The liver is a fundamental organ to ensure whole-body homeostasis, allowing for a proper
increase in insulin sensitivity from the fast to the postprandial status. Hepatic regulation of …